Candel Therapeutics, Inc. (CADL)
NASDAQ·Healthcare·Biotechnology
$9.18
+4.97%
Mkt Cap $615.21M
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (4 analysts)
$23.33
Range $22.00 – $25.00
Implied Upside
+154.1%
Consensus $23.33 vs current $9.18
NASDAQ·Healthcare·Biotechnology
$9.18
+4.97%
Mkt Cap $615.21M
Buy
2
Hold
1
Sell
0
Price Target (4 analysts)
$23.33
Range $22.00 – $25.00
+154.1%
Consensus $23.33 vs current $9.18